These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30910633)

  • 1. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.
    Dul M; Nikolic T; Stefanidou M; McAteer MA; Williams P; Mous J; Roep BO; Kochba E; Levin Y; Peakman M; Wong FS; Dayan CM; Tatovic D; Coulman SA; Birchall JC;
    Int J Pharm; 2019 May; 562():303-312. PubMed ID: 30910633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes.
    Zhao X; Birchall JC; Coulman SA; Tatovic D; Singh RK; Wen L; Wong FS; Dayan CM; Hanna SJ
    J Control Release; 2016 Feb; 223():178-187. PubMed ID: 26739548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides.
    Singh RK; Malosse C; Davies J; Malissen B; Kochba E; Levin Y; Birchall JC; Coulman SA; Mous J; McAteer MA; Dayan CM; Henri S; Wong FS
    Nanomedicine; 2021 Feb; 32():102321. PubMed ID: 33184020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes.
    Arikat F; Hanna SJ; Singh RK; Vilela L; Wong FS; Dayan CM; Coulman SA; Birchall JC
    J Control Release; 2020 Jun; 322():593-601. PubMed ID: 32087298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
    Tatovic D; McAteer MA; Barry J; Barrientos A; Rodríguez Terradillos K; Perera I; Kochba E; Levin Y; Dul M; Coulman SA; Birchall JC; von Ruhland C; Howell A; Stenson R; Alhadj Ali M; Luzio SD; Dunseath G; Cheung WY; Holland G; May K; Ingram JR; Chowdhury MMU; Wong FS; Casas R; Dayan C; Ludvigsson J
    Immunother Adv; 2022; 2(1):ltac002. PubMed ID: 35919496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans.
    Hanna SJ; Thayer TC; Robinson EJS; Vinh NN; Williams N; Landry LG; Andrews R; Siah QZ; Leete P; Wyatt R; McAteer MA; Nakayama M; Wong FS; Yang JHM; Tree TIM; Ludvigsson J; Dayan CM; Tatovic D
    Front Immunol; 2023; 14():1276255. PubMed ID: 37908349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.
    Climent N; García I; Marradi M; Chiodo F; Miralles L; Maleno MJ; Gatell JM; García F; Penadés S; Plana M
    Nanomedicine; 2018 Feb; 14(2):339-351. PubMed ID: 29157976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy.
    Cruz LJ; Rueda F; Cordobilla B; Simón L; Hosta L; Albericio F; Domingo JC
    Mol Pharm; 2011 Feb; 8(1):104-16. PubMed ID: 21121669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
    de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
    J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different-Sized Gold Nanoparticle Activator/Antigen Increases Dendritic Cells Accumulation in Liver-Draining Lymph Nodes and CD8+ T Cell Responses.
    Zhou Q; Zhang Y; Du J; Li Y; Zhou Y; Fu Q; Zhang J; Wang X; Zhan L
    ACS Nano; 2016 Feb; 10(2):2678-92. PubMed ID: 26771692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models.
    Almeida JPM; Lin AY; Figueroa ER; Foster AE; Drezek RA
    Small; 2015 Mar; 11(12):1453-1459. PubMed ID: 25354691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting.
    Fan L; Campagnoli S; Wu H; Grandi A; Parri M; De Camilli E; Grandi G; Viale G; Pileri P; Grifantini R; Song C; Jin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):103. PubMed ID: 26373379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
    Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: effects of surface coating, size and protein corona.
    Riviere JE; Jaberi-Douraki M; Lillich J; Azizi T; Joo H; Choi K; Thakkar R; Monteiro-Riviere NA
    Nanotoxicology; 2018 Dec; 12(10):1093-1112. PubMed ID: 29856247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
    Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
    ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new anti-cancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles.
    Chen WH; Chen JX; Cheng H; Chen CS; Yang J; Xu XD; Wang Y; Zhuo RX; Zhang XZ
    Chem Commun (Camb); 2013 Jul; 49(57):6403-5. PubMed ID: 23752706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting dendritic cells through gold nanoparticles: A review on the cellular uptake and subsequent immunological properties.
    Ahmad S; Zamry AA; Tan HT; Wong KK; Lim J; Mohamud R
    Mol Immunol; 2017 Nov; 91():123-133. PubMed ID: 28898717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.